ResearcherCentre international de recherche sur le cancerNo recent work listed

Maria I. Zvereva

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7432-1574; OpenAlex author ID A5037097322. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper

Papers 1

Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA. Co-author DOI 10.1016/j.ebiom.2019.09.042 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Paul Brennan · 1 shared paper, 2020 · strength 0.09
- Paper Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments … DOI 10.1016/j.ebiom.2019.09.042 ↗
Vladimír Janout · 1 shared paper, 2020 · strength 0.09
- Paper Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments … DOI 10.1016/j.ebiom.2019.09.042 ↗
Ghislaine Scélo · 1 shared paper, 2020 · strength 0.09
- Paper Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments … DOI 10.1016/j.ebiom.2019.09.042 ↗
Florence Le Calvez‐Kelm · 1 shared paper, 2020 · strength 0.09
- Paper Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments … DOI 10.1016/j.ebiom.2019.09.042 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.